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Cry1 delta-endotoxins of Bacillus thuringiensis are generally active against lepidopteran insects, but Cry1Ba
and Cry1Ia have additional, though low, levels of activity against coleopterans such as the Colorado potato
beetle. Here we report the construction of Cry1Ba/Cry1Ia hybrid toxins which have increased activities against
this insect species.
Bacillus thuringiensis is a gram-positive bacterium which pro-
duces insecticidal crystal (Cry) proteins during sporulation.
The crystal proteins form a large family of homologous, but
different, proteins with unique specificities. Each protein is
active against only one or a few insect species (for reviews, see
references 6 and 20).
Proteins of the Cry3 (12, 17), Cry7 (14), and Cry8 (19)
classes are active against insects of the order Coleoptera (bee-
tles and weevils). Cry3Aa is the most active natural protein for
the important potato pest Leptinotarsa decemlineata (Say)
(Colorado potato beetle; CPB). Cry1 proteins are generally
active against lepidopterans. However, Cry1Ba and Cry1Ia
have been shown to also have activities against coleopterans,
although their toxicity for CPB is much lower than that of
Cry3Aa (2, 21).
Cry proteins are formed as protoxins, which are activated by
proteases of the insect gut. This involves cleavage of an N-
terminal peptide and, in the larger Cry1 protoxins (but not in
Cry3), of a C-terminal extension. Structure determination by
X-ray crystallography has shown that the activated toxins of
different, and probably most, Cry proteins share a common
three-domain structure (11, 16). N-terminal domain I is
thought to insert into the target membrane and form part of
the pores that eventually kill the target insect’s gut epithelial
cells (20). Both domain II and C-terminal domain III are more
varied and have been shown to be main determinants of activ-
ity against specific insects (1, 4, 9, 10). Although it is not yet
clear how these domains may individually or collectively de-
termine specificity, there is strong evidence that both can be
involved in binding to receptors (3, 4, 5, 8, 15). Exchange of
domain III between toxins, for example, by in vivo recombina-
tion of their genes, may alter the specificity of a toxin (1).
Additionally, it may result in a hybrid toxin with a toxicity for
certain insects that is higher than that of its parent toxins (7).
So far, the latter phenomenon has been described only for
lepidopteran insects. In this paper, we show that combination
of parts of Cry1Ba and Cry1Ia results in hybrids with increased
activities against CPB, which is a coleopteran.
Expression vectors. All used Cry protein expression vectors
are based on pBD12, a derivative of pKK233-2 (1). The
Cry1Ba expression vector pMH19 has been described previ-
ously (9). The Cry1Ia expression vector pBD172 contains the
full cry1Ia gene with the SpeI site (nucleotide 2180) fused to
the SpeI site in the polylinker in pBD12, which is derived from
pBluescript SK(). For Cry3Aa expression, the cry3Aa gene
was given an NcoI site at its start by site-directed mutagenesis.
An NcoI-XmnI fragment (nucleotides 1 to 1935) was combined
with an XmnI-BglII linker, restoring the full coding region, and
was used to replace the cry1Ab gene in the expression vector
pBD1400 (7), giving the Cry3Aa expression vector pMH10.
Cry1Ia/Cry1Ba and Cry1Ba/Cry1Ia hybrids. In order to be
able to directly exchange the domain III-encoding regions be-
tween cry1Ba and cry1Ia, a new common restriction enzyme
recognition site was made in both genes by site-directed mu-
tagenesis. Complementary mutagenic oligonucleotide pairs
were used to create unique RsrII sites at positions 1464 and
1488 of cry1Ba(pMH19) and cry1Ia(pBD172), respectively, us-
ing a QuickChange kit (Stratagene) without changing the en-
coded amino acid sequences (Fig. 1A). Alignment of the
Cry1Ba and Cry1Ia amino acid sequences with that of Cry1Aa,
for which the three-dimensional structure has been established
(11), shows that this region in Cry1Aa is located in a conserved
region between the last beta strand of domain II (11) and the
following beta strand of domain III (12). These unique re-
striction sites allowed swapping of NcoI-RsrII fragments be-
tween pSN17 (cry1Ba) and pSN18 (cry1Ia). This resulted in
plasmids pSN15 and pSN16, encoding hybrids with the domain
compositions 1Ia/1Ia/1Ba and 1Ba/1Ba/1Ia, respectively (Fig.
2). pSN19, encoding a hybrid with the domain composition
1Ba/1Ia/1Ba, was made by replacing an NcoI-MunI (nucleo-
tides 1 to 896) fragment encoding domain I of Cry1Ia in pSN15
by the corresponding fragment encoding domain I of Cry1Ba
(nucleotides 1 to 869) derived from pSN16 (Fig. 1B). Align-
ment with the amino acid sequence and structure of Cry1Aa
(11) shows that this region of Cry1Aa is located between beta
strand 1a, which directly follows domain I but is structurally
a part of domain III, and the first beta strand of domain II,
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1b. Therefore, this step not only changes the entire domain I
into that of Cry1Ba but also completes domain III of Cry1Ba,
which in SN16 contains the area homologous to strand 1a
derived from Cry1Ia.
Protein isolation and insect bioassays. For large-scale pro-
duction, all parental and hybrid protoxins were expressed in E.
coli strain XL-1, extracted, and solubilized as described previ-
ously (1). Solubilized protoxins were dialyzed overnight against
25 mM NaHCO3–100 mM NaCl, pH 10. Protein concentra-
tions were estimated in duplicate by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis using a standard curve of
bovine serum albumin. To test toxicity to CPB, leaflets of
greenhouse-grown potato cultivar Desiree plants were dipped
in protoxin dilutions in water containing 0.01% Tween 20.
After air drying of the leaves, they were transferred to petri
dishes and 10 neonate CPB larvae were placed on each leaf.
After incubation for 2 days at room temperature, the leaves
were replaced by fresh leaves dipped in identical protoxin
dilutions. Mortality was scored after 4 days. Cry3Aa was ana-
lyzed as a positive control and for comparison. Fifty percent
lethal concentrations (LC50s) and 95% fiducial limits were
determined by Probit analysis of results from three or more
independent experiments using the PoloPC computer program
(18). Results of bioassays are shown in Fig. 2.
Cry1Ba/Cry1Ia hybrid protein SN16 had very low toxicity
against CPB, and not enough protoxin was purified to deter-
mine a reliable LC50. Surprisingly, the Cry1Ia/Cry1Ba hybrid
SN15 was more toxic than both of the parent proteins. When
the size differences are taken into consideration, SN15 is po-
tentially 2.5 times more toxic than Cry1Ia and 7.5 times more
toxic than Cry1Ba on a per-mole basis. This finding indicates
that domain I or II of Cry1Ia or both domains are important
determinants of the higher activity of Cry1Ia relative to that of
Cry1Ba. However, the combination with domain III and the
protoxin-specific C-terminal part of Cry1Ba renders the result-
ing hybrid even more toxic than Cry1Ia. We therefore conclude
that, also for coleopterans, hybrid toxins resulting from domain
swapping may have improved properties, as was shown earlier
to be the case for lepidopterans. The additional domain I
substitution giving a mosaic 1Ba/1Ia/1Ba hybrid (SN19) in-
creased toxicity even further, resulting in activity approaching
that of Cry3Aa against CPB. This result not only identifies
Cry1Ia domain II, and not domain I, as its most important
determinant for activity against CPB but also emphasizes the
point that new domain combinations may result in higher ac-
tivity.
New combinations of the receptor binding domains II and
III resulted in increased activities of hybrids for several lepi-
dopterans (7, 10). The molecular mechanisms underlying this
effect are not well understood, although studies of Cry1Ac
binding to a putative receptor, Lymantria dispar aminopepti-
dase N, suggested that domain II and domain III confer two
separate steps in binding to this protein in a two-step model
and that one step may be rate limiting for that binding (13).
Following this line of reasoning, one could speculate that both
Cry1Ba and Cry1Ia bind to the same receptor in CPBs but that
different steps are rate limiting for the 2 toxins. Hence, the
proper combination of domains II and III may optimize both
binding steps and thus increase activity. Furthermore, the com-
bination of these domains with domain I of Cry1Ba is more
active. Since both Cry1Ba and SN19 have extended protoxin-
specific C-termini compared to that of Cry1Ia, the possibility of
a role of these extensions in the higher toxicity of SN19 cannot
yet be excluded. This, however, would be contrary to the find-
ings of Lambert et al. for Cry7Aa, which was found to be active
FIG. 1. (A) Oligonucleotides used to create RsrII sites in the
cry1Ba and cry1Ia genes by mutagenesis and the amino acids encoded
by the respective parts of the genes. The two mutated nucleotides of
the wild-type genes are shown above and below the oligonucleotide
sequences. (B) Localization of the common MunI site in cry1Ba and
cry1Ia genes and the amino acids encoded by the respective parts of the
genes.
FIG. 2. Domain compositions and insecticidal activities of Cry1Ia/
Cry1Ba hybrids and their parental protoxins. Bioassays were per-
formed with solubilized protoxins on potato leaves with neonate CPBs.
Concentrations (LC50s) are expressed as micrograms per milliliter of
dipping solution. Ninety-five percent fiducial limits are shown in pa-
rentheses. ND, not determined. The column of data labeled “Relative”
gives toxicities relative to that of Cry3Aa on a per-mole basis: (molec-
ular weight of protein/molecular weight of Cry3Aa)  (LC50 of
Cry3Aa/LC50 of protein)  100.
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against CPB only after solubilization and activation (14). In
this study we have tested solubilized protoxins, while it was
shown earlier for Cry1Ba that solubilization prior to testing
was necessary for high activity against CPB (2). This need may
be caused by the relatively low gut pH (pH 6 to 7) in CPB,
compared to that in lepidopterans, which inhibits solubilization
of the crystalline protoxin. Whether this inhibition would pre-
vent effective application of SN19 in a crystalline form and
whether SN19 may be an alternative for Cry3Aa in CPB-resis-
tant transgenic plants are the subjects of our further studies.
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